Dakshidin Corporation, Inc. (DKSC)

0.0012 0.0000 (0.00%) At close: 10:49AM EDT

Dakshidin Corporation, Inc.

2250 NW 114th Avenue
Unit 1P
Miami, FL 33172-3652
United States
888-818-9167

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Christopher Robin Haigh	CEO & Director	N/A	N/A	N/A
Mr. Charles L. Nuzum Sr., CPA	CFO & Sec. to the Board of Directors	N/A	N/A	1949
Mr. Robert Mack Peak	Chief Marketing Officer	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Dakshidin Corporation, Inc., through its subsidiaries, operates as a CBD/cannabis-based medical product company. It cultivates cannabis; and operates an online sales portal for CBD products. The company also manages distribution channel programs in the retail distribution, reselling, and direct sales market segments. Dakshidin Corporation, Inc. was formerly known as Avrada, Inc. and changed its name to Dakshidin Corporation, Inc. in February 2007. The company is based in Miami, Florida with additional offices in Las Vegas, Nevada.

Corporate governance

Dakshidin Corporation, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.